Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06544135 · ClinicalTrials.gov registry record
Use of Thermal Imaging Camera to Assess Perfusion Before and After Vascular Intervention
A clinical trial of Peripheral Arterial Disease and Critical Limb Ischemia, sponsored by University Hospitals Cleveland Medical Center.
- Recruiting
- Registry status
- 25
- Enrollment target
- 3
- Study locations
NCT06544135: Recruiting study of Peripheral Arterial Disease and Critical Limb Ischemia, sponsored by University Hospitals Cleveland Medical Center.
NCT06544135 is a study of Peripheral Arterial Disease and Critical Limb Ischemia that is actively recruiting participants, run by University Hospitals Cleveland Medical Center. The registered enrollment target is 25 participants, below the 4,206-participant average among 79 other Peripheral Arterial Disease trials with a reported enrollment target (99% lower). The trial reports 3 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06544135, a study of Peripheral Arterial Disease and Critical Limb Ischemia, is actively recruiting participants, sponsored by University Hospitals Cleveland Medical Center.
- RECRUITING
- Registry status
- 25 participants
- Enrollment target
- 3
- Study locations
Study Summary
This is a preliminary prospective observational study measuring change in lower extremity temperature in response to revascularization procedure. The main question this study aims to answer is: \- Are temperature measurements from a forward looking infrared (FLIR) camera of the lower extremity useful in predicting outcome of revascularization procedures?
Primary Outcome
Ankle brachial index will be taken before and after intervention and correlated with thermal readings from FLIR.
Conditions Studied
Interventions
- DEVICE FLIR One Pro LT
Study Locations (3)
Ohio
- University Hospitals Ahuja Medical Center - Beachwood
- University Hospitals Cleveland Medical Center - Cleveland
- University Hospitals Parma Medical Center - Parma
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 25 participants |
| Start Date | 2025-04-14 |
| Est. Completion | 2027-10 |
What NCT06544135 shows while recruiting
NCT06544135 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 25 participants, a relatively small participant target, below the 4,206-participant average among 79 other Peripheral Arterial Disease trials with a reported enrollment target (99% lower).
The record links to 3 conditions, with Peripheral Arterial Disease appearing as the primary indexed condition, and to 1 intervention - of which FLIR One Pro LT is the first listed.
NCT06544135 reports a single indexed study location in Ohio.
Frequently Asked Questions
What is clinical trial NCT06544135 about?
NCT06544135 is a clinical study titled "Use of Thermal Imaging Camera to Assess Perfusion Before and After Vascular Intervention". This is a preliminary prospective observational study measuring change in lower extremity temperature in response to revascularization procedure. The main question this study aims to answer is: \- Are temperature measurements from a forward looking infrared (FLIR) camera of the lower extremity use...
What is the current status of trial NCT06544135?
This trial is currently recruiting. The enrollment target is 25 participants. The study started on 2025-04-14. Estimated completion is 2027-10.
What conditions does trial NCT06544135 study?
This clinical trial studies the following conditions: Peripheral Arterial Disease, Critical Limb Ischemia, Critical Lower Limb Ischemia.
What interventions are being tested in trial NCT06544135?
The interventions under investigation include: FLIR One Pro LT (DEVICE).
Who is sponsoring clinical trial NCT06544135?
This trial is sponsored by University Hospitals Cleveland Medical Center, which has 230 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06544135 being conducted?
This trial has 3 study locations across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Peripheral Arterial Disease
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06544135's enrollment target sits among peer trials
25 61st of 79 higher than 19 of 79 other Peripheral Arterial Disease trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Peripheral Arterial Disease trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
SELUTION4BTK Trial
RECRUITING · NA
-
MitoQ Treatment of Claudication: Myofiber and Micro-vessel Pathology
RECRUITING · NA
-
A Real-World Registry of Chronic Wounds and Ulcers
RECRUITING
-
Low Dose ColchicinE in pAtients With Peripheral Artery DiseasE to Address Residual Vascular Risk
RECRUITING · Phase 3
-
Ramipril Treatment of Claudication: Oxidative Damage and Muscle Fibrosis
RECRUITING · Phase 4
-
Ultrasound Perfusion Estimation for Assessment of Peripheral Arterial Disease
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01166854 · 25 participants
Characterization of Familial Myopathy and Paget Disease of Bone
- NCT01913106 · 25 participants · Phase 1
HSV-tk + Valacyclovir Therapy in Combination With Brachytherapy for Recurrent Prostate Cancer
- NCT02138669 · 25 participants · NA
Intacs Prescription Inserts for Keratoconus Patients
- NCT02174549 · 25 participants · Phase 1
Dose-defining Study of Tirapazamine Combined With Embolization in Liver Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI